Primary and secondary osteoarthritis.
Hypersensitivity to , other components (including to the anthraquinone medicines (laxatives), age testosterone enanthate cycle 18 years. Lactose intolerance, lactase deficiency, malabsorption glyukozogalaktoznaya
Severe liver or kidney failure, intestinal obstruction, inflammatory bowel disease.
Pregnancy and lactation
The drug is contraindicated during pregnancy and lactation.
When receiving the drug should be abolished breastfeeding.
Dosing and Administration
Inside, after eating, you must be swallowed whole, without chewing, drinking water, 50 mg 2 times a day (morning and evening).
Continuous long-term or courses (at least 4 months).
Diafleks Rompharm during the first 2 weeks may cause transit acceleration in the intestines, so it is recommended to start treatment with one capsule in the evening with food for 4 weeks. Thereafter, the dosage was increased to 100 mg / day.
From the digestive system: diarrhea, nausea, vomiting, abdominal pain, hepatitis. Allergic reactions: rash, fever, bronchospasm, angioedema, anaphylactic shock. Other: malaise, intense staining of urine (depending on pH) from yellow to brown (no clinical significance).
Symptoms: diarrhea, weakness. Treatment: symptomatic. In severe diarrhea should be monitored plasma electrolyte composition.
Interaction with other drugs
Diafleks Rompharm recommended not to be taken with drugs that increase the volume of intestinal contents (for example, a large amount of fiber). Antacids reduce the absorption of the drug. At simultaneous reception with antibiotics or chemotherapeutic drugs affecting the intestinal microflora, may increase the frequency of adverse events on the part of the intestine.
The medicaments (drugs) containing aluminum hydroxide and / or magnesium hydroxide, reduce bioavailability of .
Concomitant use is not recommended with laxatives.
Duration of treatment may be prolonged. Prior to the onset of the therapeutic effect of testosterone enanthate cycle can be taken together with analgesic drugs (including NSAIDs). A periodic monitoring blood counts, liver function tests (to determine the level of hepatic transaminases), urine (creatinine levels and creatinine clearance). When renal function deterioration is necessary to reduce the dose of the drug.
In patients with chronic renal failure, at least 30 ml QC / min dose should be lowered to 50 mg / day and then titrated according to the clinical efficacy and tolerability.
Staining urine can interfere with the interpretation of urine analysis results (eg, glucose).
Effects on ability to drive vehicles, machinery
Capsules 50 mg.
10 capsules in blisters made of PVC / aluminum foil.
3 blisters with instruction on use is placed in a cardboard box.
In the dark place at a temperature no higher than 25 ° C.
In the reach of children.
Do not use after the testosterone enanthate cycle expiration date.
Conditions of supply